Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding
BJU International, 08/14/09
Rouach Y et al. – In a trial to evaluate the prognostic impact of capsular involvement (CaI) in pts treated exclusively with partial nephrectomy (PN) for localized renal cell carcinoma (RCC), it was found that in a contemporary series of pts exclusively treated with PN for localized RCC, CaI was not predictive of disease recurrence and disease-specific mortality. These results do not support the use of any change in postoperative management in pts with CaI after PN.
Methods- Medical records were reviewed of pts treated with PN for a sporadic and localized RCC (pT1-pT2N0M0).
- Univariate and multivariate analysis using a Cox proportional-hazards regression analysis were conducted to identify significant predictors of oncological outcome for several clinical and pathological factors, ie, imperative indication, histological type, Fuhrman grade, tumour size, T stage, CaI, and surgical margins.
- Disease-free and -specific survival rates of pts with CaI and no evidence of CaI were compared using the log-rank test.
- 305 pts had a PN for localized RCC, of whom 22 (7.2%) had CaI in the PN specimen.
- Median (range) follow-up was 6 (1.5–23) yrs.
- Multivariate statistical analysis showed that imperative indication for PN and high-grade RCC were independently associated with worse disease-free and -specific survival, whereas CaI had no prognostic value.
- Disease-free and -specific survival in pts with and without CaI were not significantly different at 5 and 10 yrs.
Related Articles
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 90%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 90%
Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma
The Journal of Urology, 11/18/09
Relevance Score: 89%
Laparoscopic Radical Nephrectomy for Renal Cell Carcinoma: Oncological Outcomes at 10 Years or More
The Journal of Urology, 10/15/09
Relevance Score: 89%
Positive Surgical Margins With Renal Cell Carcinoma Have a Limited Influence on Long-term Oncological Outcomes of Nephron Sparing Surgery
Urology, 11/12/09
Relevance Score: 88%
Today in Kidney...keeping you current
Receive free subspecialty "5-minute updates" via email
Laparoscopic radical and partial nephrectomy
Der Urologe, 12/11/09
Current status of nephron-sparing robotic partial nephrectomy
Current Opinion in Urology, 12/11/09
Percutaneous nephrolithotomy in a patient with intrarenal arterial aneurysm
Urological Research - Urolithiasis, 12/11/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/11/09
[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study
European Journal of Cancer, 12/11/09
HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
The Prostate, 12/11/09
Article Search
Sponsor


See Latest Articles


